| Title : bPiDI: a novel selective alpha6beta2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse - Wooters_2011_Br.J.Pharmacol_163_346 |
| Author(s) : Wooters TE , Smith AM , Pivavarchyk M , Siripurapu KB , McIntosh JM , Zhang Z , Crooks PA , Bardo MT , Dwoskin LP |
| Ref : British Journal of Pharmacology , 163 :346 , 2011 |
| Abstract : Wooters_2011_Br.J.Pharmacol_163_346 |
| ESTHER : Wooters_2011_Br.J.Pharmacol_163_346 |
| PubMedSearch : Wooters_2011_Br.J.Pharmacol_163_346 |
| PubMedID: 21232049 |
Wooters TE, Smith AM, Pivavarchyk M, Siripurapu KB, McIntosh JM, Zhang Z, Crooks PA, Bardo MT, Dwoskin LP (2011)
bPiDI: a novel selective alpha6beta2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse
British Journal of Pharmacology
163 :346
Wooters TE, Smith AM, Pivavarchyk M, Siripurapu KB, McIntosh JM, Zhang Z, Crooks PA, Bardo MT, Dwoskin LP (2011)
British Journal of Pharmacology
163 :346